logo
  • About
    • Leadership & Team
    • Board of Directors
    • Clinical Collaborations
    • Value Proposition
  • Technology
    • Development Challenges
    • Groundbreaking Solution
    • Liquid Structure™ Technology
  • Investigational Drugs
    • Nantheia™ A1002
    • Nantheia™ ATL5
    • Research and Development
    • Manufacturing
      • Supply Chain
      • Analytical Testing
    • Drug Master Files
  • Clinical Programs
    • Pipeline
    • Clinical Trials
      • NYU PTSD
      • UNMC PTSD
      • UCLA Opioid Use
      • Mt. Sinai Phase I
      • NYU Social Anxiety
      • NYU Neuropathic Pain
    • Trial Infrastructure
      • Protocol Design & Development
      • Statistical Analysis
    • Trial Monitoring & Compliance
  • News
    • Press Releases
    • News Archive
  • Contact Us
    • Investigators
    • Investors
    • Media Contact
  • About
    • Leadership & Team
    • Board of Directors
    • Clinical Collaborations
    • Value Proposition
  • Technology
    • Development Challenges
    • Groundbreaking Solution
    • Liquid Structure™ Technology
  • Investigational Drugs
    • Nantheia™ A1002
    • Nantheia™ ATL5
    • Research and Development
    • Manufacturing
      • Supply Chain
      • Analytical Testing
    • Drug Master Files
  • Clinical Programs
    • Pipeline
    • Clinical Trials
      • NYU PTSD
      • UNMC PTSD
      • UCLA Opioid Use
      • Mt. Sinai Phase I
      • NYU Social Anxiety
      • NYU Neuropathic Pain
    • Trial Infrastructure
      • Protocol Design & Development
      • Statistical Analysis
    • Trial Monitoring & Compliance
  • News
    • Press Releases
    • News Archive
  • Contact Us
    • Investigators
    • Investors
    • Media Contact

Pipeline

clinical trial pipeline

Home | Clinical Programs | Pipeline

  • Clinical Programs
  • Pipeline
  • Clinical Trials
    • NYU PTSD
    • UNMC PTSD
    • UCLA Opioid Use
    • Mt. Sinai Phase I
    • NYU Social Anxiety
    • NYU Neuropathic Pain
  • Trial Infrastructure
    • Protocol Design & Development
    • Statistical Analysis
  • Monitoring & Compliance
  • Clinical Programs
  • Pipeline
  • Clinical Trials
    • NYU PTSD
    • UNMC PTSD
    • UCLA Opioid Use
    • Mt. Sinai Phase I
    • NYU Social Anxiety
    • NYU Neuropathic Pain
  • Trial Infrastructure
    • Protocol Design & Development
    • Statistical Analysis
  • Monitoring & Compliance
“

We place patients and their families first on our mission to develop medicines and create lasting change.

  • About
  • Leadership & Team
  • Board of Directors
  • Clinical Collaborations
  • Value Proposition
  • About
  • Leadership & Team
  • Board of Directors
  • Clinical Collaborations
  • Value Proposition
  • Technology
  • Development Challenges
  • Groundbreaking Solution
  • Liquid Structure™ Technology
  • Technology
  • Development Challenges
  • Groundbreaking Solution
  • Liquid Structure™ Technology
  • Investigational Drugs
  • Investigational Drugs
    • Nantheia™ A1002
    • Nantheia™ ATL5
  • Research and Development
  • Manufacturing
    • Supply Chain
    • Analytical Testing
  • Drug Master Files
  • Investigational Drugs
  • Investigational Drugs
    • Nantheia™ A1002
    • Nantheia™ ATL5
  • Research and Development
  • Manufacturing
    • Supply Chain
    • Analytical Testing
  • Drug Master Files
  • Clinical Programs
  • Pipeline
  • Clinical Trials
    • NYU PTSD
    • UNMC PTSD
    • UCLA Opioid Use
    • Mt. Sinai Phase I
    • NYU Social Anxiety
    • NYU Neuropathic Pain
  • Trial Infrastructure
    • Protocol Design & Development
    • Statistical Analysis
  • Monitoring & Compliance
  • Clinical Programs
  • Pipeline
  • Clinical Trials
    • NYU PTSD
    • UNMC PTSD
    • UCLA Opioid Use
    • Mt. Sinai Phase I
    • NYU Social Anxiety
    • NYU Neuropathic Pain
  • Trial Infrastructure
    • Protocol Design & Development
    • Statistical Analysis
  • Monitoring & Compliance
  • News
  • Press Releases
  • News Archive
  • News
  • Press Releases
  • News Archive
  • Contact Us
  • Investigators
  • Investors
  • Media Contact
  • Contact Us
  • Investigators
  • Investors
  • Media Contact
  • About
  • Technology
  • Investigational Drugs
  • Clinical Programs
  • News
  • Contact Us
  • About
  • Technology
  • Investigational Drugs
  • Clinical Programs
  • News
  • Contact Us
footer_logo

Copyright © 2024 ANANDA Scientific, Inc. All Rights Reserved.